Generation of a Novel Regulatory NK Cell Subset from Peripheral Blood CD34 + Progenitors Promoted by Membrane-Bound IL-15
Massimo Giuliani, Julien Giron-Michel, Simone Negrini et al. · 2008
Read Generation of a Novel Regulatory NK Cell Subset from Peripheral Blood CD34 + Progenitors Promoted by Membrane-Bound IL-15 by Massimo Giuliani, Julien Giron-Michel, Simone Negrini et al. (2008) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0002241.txt.
Introduction
Massimo Giuliani and co-authors grew a new kind of regulatory immune cell from blood stem cells, in a 2008 PLOS ONE paper. Natural killer cells are known as killers of virus-infected and tumor cells. They can also regulate the immune system, but whether a defined NK subset does the regulating was in doubt.
The team used membrane-bound IL-15, a growth signal fixed to a surface, to guide blood CD34 progenitor cells into a novel regulatory NK subset. A lab source of calming immune cells could one day help control unwanted immune attacks, in transplantation or autoimmune disease.
Catalog record
| CREATOR | Massimo Giuliani, Julien Giron-Michel, Simone Negrini et al. |
|---|---|
| YEAR | 2008 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 67 KB |
| LICENSE | Creative Commons Attribution License |
| RIGHTS | CC BY |
| SOURCE | PLOS ONE |
Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0002241
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
Generation of a Novel Regulatory NK Cell Subset from Peripheral Blood CD34 + Progenitors Promoted by Membrane-Bound IL-15 Authors: Massimo Giuliani, Julien Giron-Michel, Simone Negrini, Paola Vacca, Deniz Durali, Anne Caignard, Caroline Le Bousse-Kerdiles, Salem Chouaib, Aurore Devocelle, Rajia Bahri, Antoine Durrbach, Yassine Taoufik, Silvano Ferrini, Michela Croce, Maria Cristina Mingari, Lorenzo Moretta, Bruno Azzarone Published: 2008, PLOS ONE DOI: 10.1371/journal.pone.0002241 ABSTRACT NK cells have been long time considered as cytotoxic lymphocytes competent in killing virus-infected cells and tumors. However, NK cells may also play essential immuno-regulatory functions. In this context, the real existence of a defined NK subset with negative regulatory properties has been hypothesized but never clearly demonstrated. Herein, we show the in vitro generation from human peripheral blood haematopoietic progenitors (PB-HP), of a novel subset of non-cytolytic NK cells displaying a mature phenotype and remarkable immuno-regulatory functions (NK-ireg). The main functional hallmark of these NK-ireg cells is represented by the surface expression/release of HLA-G, a major immunosuppressive molecule. In addition, NK-ireg cells secrete two powerful immuno-regulatory factors: IL-10 and IL-21. Through these factors, NK-ireg cells act as effectors of the down-regulation of the immune response: reconverting mature myeloid DC (mDC) into immature/tolerogenic DC, blocking cytolytic functions on conventional NK cells and inducing HLA-G membrane expression on PB-derived monocytes. The generation of “NK-ireg” cells is obtained, by default, in culture conditions favouring cell-to-cell contacts, and it is strictly dependent on reciprocal trans-presentation of membrane-bound IL-15 forms constitutively and selectively expressed by human CD34 + PB-HP. Finally, a small subset of NKp46 + HLA-G + IL-10 + is detected within freshly isolated decidual NK cells, suggesting that these cells could represent an in vivo counterpart of the NK-ireg cells. In conclusion, NK-ireg cells represent a novel truly differentiated non-cytolytic NK subset with a self-sustainable phenotype (CD56 + CD16 + NKp30 + NKp44 + NKp46 + CD94 + CD69 + CCR7 + ) generated from specific pSTAT6 + GATA3 + precursors. NK-ireg cells could be employed to develop new immuno-suppressive strategies in autoimmune diseases, transplant rejection or graft versus host diseases. In addition, NK-ireg cells can be easily derived from peripheral blood of the patients and could constitute an autologous biotherapic tool to be used combined or in alternative to other immuno-regulatory cells. INTRODUCTION Natural Killer (NK) cells, traditionally considered to be major innate effector cells, have been long time relegated to the job of killing virus-infected cells and tumors. However, more and more evidence has been obtained that NK cells play positive or negative regulatory effect by secreting various cytokines or cell-to-cell contact and maintain immune homeostasis [1] – [5] . As a consequence, subsets of NK cells in mouse and human have been defined based on their cell-surface phenotype and functional properties that are shaped by environmental factors among which cytokines play a major role [1] – [5] . In this context, the differentiation of CD34 + HP into NK cells is strictly dependent on Interleukin 15 (IL-15) [6] , [7] . However, the mechanism by which IL-15 mediates NK cell differentiation is not fully understood and it seems to be only partially dependent on the soluble form of this cytokine. Although soluble IL-15 can bind to the IL-15R complex and induce signals in a manner similar to other cytokines upon interaction with their receptors [8] , [9] , there is increasing evidence that IL-15 mediates many specific biological responses in cell membrane-associated forms [10] – [12] . In this context, membrane-bound IL-15 (mb-IL-15) anchored through the IL-15Rα chain on the surface of Bone Marrow (BM) myeloid accessory cells, in the mouse model, is essential for normal development of NK cells [13] , [14] , whereas IL-15 trans -presentation seems to be more complex in human as suggested by the detection of additional forms of mb-IL-15 independent on the IL-15Rα [10] , [12] . Indeed, human spleen myofibroblasts display a mb-IL-15 associated with IL-15Rβγc chains [12] , which is necessary and sufficient to trigger in vitro the differentiation of circulating progenitors into cytolytic NK cell [15] . Finally, prostate cancer cells express a trans- membrane IL-15, anchored in a IL-15R-independent fashion, which can participate in reverse signaling and/or act in a juxtacrine fashion promoting the development of bystander cells [10] . These data indicate that IL-15 trans-presentation by accessory cells seems to be an important requirement for NK cell homeostasis [13] - [15] , while it is still poorly defined whether IL-15 trans-presented by CD34 + HP may play a role in this process. In this respect, we have recently observed that human uncommitted CD34 + PB-HP constitutively express mb-IL-15 [16] , the involvement of which in the commitment towards the NK differentiation pathway has not been explored. In order to clarify this point, we expanded human CD34 + PB-HP adapting previously described protocols, based on the use of media supplemented with stem cell factor (SCF) and flt3 ligand (FL), that induce an enrichment in CD34 + CD56 − NK progenitors (NKP) [17] , [18] . Surprisingly, the results revealed that membrane-bound IL-15 forms present on human PB-HP [10] , [12] , in conditions favouring cell-to-cell contact, promote, through reciprocal trans-presentation, the generation of a novel subset of mature non-cytolytic NK cells. These NK cells secrete major regulatory factors (IL-10, IL-21 and HLA-G) that likely mediate tolerogenic/immunosuppressive activities on myeloid DC maturation, on NK associated cytolytic functions and on PB monocytes phenotype and function. The real existence of a NK subset with negative regulatory functions has been hypothesized but never clearly demonstrated [2] , [5] . Herein, we show the mb-IL-15 dependent generation from human PB-HP, of a novel subset of mature non–cytolytic NK cells (NK-ireg), whose main functional hallmark is the surface expression/release of a major immunosuppressive molecule HLA-G [19] , and that display remarkable regulatory functions. MATERIALS AND METHODS Human recombinant IL-4, soluble IL-15Rα/Fc Chimera (s-IL-15Rα), soluble IL-21R/Fc Chimera (s-IL-21R), the Cytofix/Cytoperm reagent are from R&D Systems (Lille, France). Recombinant Stem Cell Factor (SCF), IL-12, IL-21, GM-CSF and FMS-like tyrosine kinase 3 ligand (Flt3-L) were purchased from Immunotools (Friesoythe, Germany). LPS ( E. Coli, 055:B5), Brefaldin A, PHA, and PMA were from Sigma-Aldrich (S. Q. Fallavier France). Antibodies used in this study are listed in table 1 . FLC = flow cytometry, W.B. = Western Blot, CF = Confocal Microscopy, Neu. = neutralization TABLE: Antibodies, origin and use Abs anti- origin use IL-15Rα (AF 247) R&D Systems (Lille, France). FLC+Neu IL-10-PE, IL-15-PE, IFNγ-FITC FLC IL-12 FLC IL-21 eBioscience (San Diego USA) W.B. IL-15Rβ (6E8) Y. Jacques (U463 INSERM, Nantes, France) Neu IL-2/IL-15-γc (TUGh4), BD PharMingen (Le Pont de Claix, France). Neu CD107a, CD85j FLC CD11c-PE, CD16-PE, CD34-PE, CD38-PE, CD56-PE, CD69-PE, HLA-DR-FITC Immunotools (Friesoythe, Germany) FLC Perforin-FITC, Granzyme B-FITC FLC CF CD80-PE, CD83-PE, CD86-PE, NKp30-PE, NKp44-PE, NKp46-PE, NKG2D-PE, CD94-PE ,CD161-PE Beckman Coulter (Villepinte, France) FLC isotype matched Ig controls FLC CCR7 BD Biosciences (San Diego, United States) FLC HLA-G (4H84), TGF-β1 pSTAT3, pSTAT6, GATA3 Santa-Cruz Biotechnologies (Tebu, Le Parray en Yvelines, France) FLC+WB W.B PE-or FITC-labeled goat anti-mouse and goat anti-rabbit Jackson ImmunoResearch Laboratories, France) FLC secondary Abs. Alexa Fluor488-labelled goat anti-rabbit and goat anti-mouse Molecular Probes, Interchim, France FLC CF secondary Abs. horseradish peroxidase (HRP) labelled goat anti mouse Amersham Biosciences, Orsay, France W.B. secondary Abs.